Detection of a novel, primate-specific ‘kill switch’ tumor suppression mechanism that may fundamentally control cancer risk in humans: an unexpected twist in the basic biology of TP53
Open Access
- 1 November 2018
- journal article
- review article
- Published by Bioscientifica in Endocrine-Related Cancer
- Vol. 25 (11) , R497-R517
Abstract
The activation of TP53 is well known to exert tumor suppressive effects. We have detected aprimate-specificadrenal androgen-mediated tumor suppression system in which circulating DHEAS is converted to DHEA specifically in cells in which TP53 has beeninactivated. DHEA is anuncompetitiveinhibitor of glucose-6-phosphate dehydrogenase (G6PD), an enzyme indispensable for maintaining reactive oxygen species within limits survivable by the cell. Uncompetitive inhibition is otherwise unknown in natural systems because it becomesirreversiblein the presence of high concentrations of substrate and inhibitor. In addition to primate-specific circulating DHEAS, a unique, primate-specific sequence motif that disables an activating regulatory site in the glucose-6-phosphatase (G6PC) promoter was also required to enable function of this previously unrecognized tumor suppression system. In human somatic cells, loss of TP53 thus triggers activation of DHEAS transport proteins and steroid sulfatase, which converts circulating DHEAS into intracellular DHEA, and hexokinase which increases glucose-6-phosphate substrate concentration. The triggering of these enzymes in the TP53-affected cell combines with the primate-specific G6PC promoter sequence motif that enables G6P substrate accumulation, driving uncompetitive inhibition of G6PD to irreversibility and ROS-mediated cell death. By this catastrophic ‘kill switch’ mechanism, TP53 mutations are effectively prevented from initiating tumorigenesis in the somatic cells of humans, the primate with the highest peak levels of circulating DHEAS. TP53 mutations in human tumors therefore represent fossils of kill switch failure resulting from an age-related decline in circulating DHEAS, a potentially reversible artifact of hominid evolution.Keywords
This publication has 177 references indexed in Scilit:
- High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole ratNature, 2013
- Transcription Pattern of p53-Targeted DNA Repair Genes in the Hypoxia-Tolerant Subterranean Mole Rat SpalaxJournal of Molecular Biology, 2013
- The High Cost of Cancer Drugs and What We Can Do About ItMayo Clinic Proceedings, 2012
- Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer riskThe Lancet Oncology, 2011
- p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenaseNature Cell Biology, 2011
- Late Pleistocene adult mortality patterns and modern human establishmentProceedings of the National Academy of Sciences, 2011
- A Comprehensive Approach to the Profiling of the Cooked Meat Carcinogens 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline, 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, and Their Metabolites in Human UrineChemical Research in Toxicology, 2010
- Sequence variation between the mouse and human glucose-6-phosphatase catalytic subunit gene promoters results in differential activation by peroxisome proliferator activated receptor gamma coactivator-1αDiabetologia, 2008
- Species-specific endogenous retroviruses shape the transcriptional network of the human tumor suppressor protein p53Proceedings of the National Academy of Sciences, 2007
- P53 in blind subterranean mole rats – loss-of-function versus gain-of-function activities on newly cloned Spalax target genesOncogene, 2006